Catalogo dei prodotti della ricerca

SALVETTI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.874
EU - Europa 5.056
AS - Asia 3.248
SA - Sud America 276
AF - Africa 120
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.766
IT - Italia 2.219
SG - Singapore 1.815
SE - Svezia 630
IN - India 589
CN - Cina 551
UA - Ucraina 394
DE - Germania 365
FI - Finlandia 331
RU - Federazione Russa 330
BR - Brasile 194
GB - Regno Unito 169
BG - Bulgaria 93
ID - Indonesia 91
CA - Canada 81
TG - Togo 80
IE - Irlanda 79
AT - Austria 75
NL - Olanda 70
AR - Argentina 64
FR - Francia 60
RO - Romania 54
TR - Turchia 52
BE - Belgio 39
AU - Australia 29
TW - Taiwan 27
HK - Hong Kong 22
IR - Iran 21
LT - Lituania 20
CH - Svizzera 19
CZ - Repubblica Ceca 18
MX - Messico 17
PL - Polonia 16
ZA - Sudafrica 14
ES - Italia 13
GR - Grecia 12
IQ - Iraq 11
AL - Albania 8
IL - Israele 8
MA - Marocco 7
PT - Portogallo 7
SC - Seychelles 7
UZ - Uzbekistan 7
VN - Vietnam 7
CL - Cile 6
JP - Giappone 6
LI - Liechtenstein 6
LV - Lettonia 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
BD - Bangladesh 4
CR - Costa Rica 4
EG - Egitto 4
EU - Europa 4
KR - Corea 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
VE - Venezuela 3
BO - Bolivia 2
CI - Costa d'Avorio 2
EC - Ecuador 2
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
IS - Islanda 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
TM - Turkmenistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DZ - Algeria 1
GE - Georgia 1
JO - Giordania 1
MU - Mauritius 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
Totale 21.612
Salva come PNG Salva come JPEG
Città #
Fairfield 2.092
Ashburn 1.449
Singapore 1.042
Chandler 950
Woodbridge 937
Houston 753
Seattle 749
Cambridge 706
Rome 675
Wilmington 606
Ann Arbor 422
Princeton 361
Beijing 360
Santa Clara 326
Fasano 297
Plano 258
Lawrence 205
Boston 203
San Paolo di Civitate 201
San Diego 166
Jacksonville 153
Cosenza 136
Dearborn 108
Norwalk 108
Helsinki 106
Millbury 106
Andover 100
Sofia 92
Jakarta 90
Moscow 88
Milan 87
Lomé 80
New York 80
Dublin 73
Boardman 71
Falkenstein 60
Toronto 60
Federal 56
Nuremberg 55
Vienna 50
Des Moines 48
Falls Church 45
Brussels 35
Bremen 34
London 30
Bühl 28
Council Bluffs 28
Yubileyny 28
Grafing 27
San Mateo 27
Pune 26
Taipei 26
Phoenix 24
Istanbul 23
Frankfurt am Main 22
Mannheim 22
Nanjing 20
Hong Kong 19
Naples 18
Paris 17
Varedo 17
Florence 16
Bologna 14
Hefei 14
Los Angeles 14
Kunming 13
Latina 13
Ankara 12
Fārsān 12
Ottawa 12
São Paulo 12
Lauterbourg 11
Stockholm 11
Amsterdam 10
Edinburgh 10
Guangzhou 10
Munich 10
Portsmouth 10
Redwood City 10
Warsaw 10
Bari 9
Belo Horizonte 9
Buffalo 9
Genoa 9
Melbourne 9
Ahmedabad 8
Brno 8
Giugliano In Campania 8
Oxford 8
Redmond 8
Zurich 8
Civitavecchia 7
Lappeenranta 7
Laurel 7
Mexico City 7
Ponzano Veneto 7
Sydney 7
Tashkent 7
Verona 7
Arielli 6
Totale 15.460
Salva come PNG Salva come JPEG
Nome #
Collaboration between a human group and artificial intelligence can improve prediction of multiple sclerosis course. A proof-of-principle study 527
B cells and multiple sclerosis 135
Machine learning use for prognostic purposes in multiple sclerosis 131
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study 130
A case of double standard. Sex differences in multiple sclerosis risk factors 122
Riluzole in patients with hereditary cerebellar ataxia. a randomised, double-blind, placebo-controlled trial 120
Conversion from clinically isolated syndrome to multiple sclerosis. a large multicentre study. 120
Noise Enhances Action Potential Generation in Mouse Sensory Neurons via Stochastic Resonance 115
Analysis of coding and non-coding transcriptome of peripheral B cells reveals an altered interferon response factor (IRF)-1 pathway in multiple sclerosis patients 113
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS 112
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 112
A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in multiple sclerosis 106
Dendritic cells loaded with apoptotic oligodendrocytes as a source of myelin T-cell epitopes in multiple sclerosis 105
Increased circulating levels of vitamin D binding protein in MS patients 105
Brainstem signs with progressing atrophy of medulla oblongata and upper cervical spinal cord 104
The T cell response to amyloid-beta to mitochondrial antigens in Alzheimer's disease 103
Considering patient clinical history impacts performance of machine learning models in predicting course of multiple sclerosis 101
La neurologia della Sapienza 100
IFN-β and multiple sclerosis: From etiology to therapy and back 100
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 98
EBNA2 binds to genomic intervals associated with multiple sclerosis and overlaps with vitamin D receptor occupancy 97
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. 97
arsenical c-glucoside derivatives with promising antitumor activity 96
070 Baseline characteristics and safety profile of patients with relapsing-remitting multiple sclerosis (RRMS) in the first interim analysis of the peginterferon BETA-1A treatment in the phase 4 plegridy observational program (POP) 96
CD161(high) CD8(+)T cells bear pathogenetic potential in multiple sclerosis 96
Involvement of the limbic system in multiple sclerosis patients with depressive disorders 95
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 95
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis. An Italian, Multicenter, Real-World Study 94
Characterization of Epstein–Barr virus genotypes in multiple sclerosis through next generation sequencing approaches 93
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 93
Twin studies in multiple sclerosis. A meta-estimation of heritability and environmentality 92
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 92
Epstein-Barr virus genetic variants are associated with multiple sclerosis 92
CADASIL or MS? Consider “Red Flags” but Avoid a Misdiagnosis: Case Series of a Concomitant Diagnosis 91
Biomarkers for multiple sclerosis 91
T cell response to N-formylated peptides in humans 91
The Italian Twin Project: From the personal identification number to a national Twin Registry 89
Bacille calmette guerin (BCG) vaccine in multiple sclerosis (MS): A single crossover study 89
A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. 89
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis 89
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 89
Drug holiday of interferon beta 1b in multiple sclerosis: A Pilot, Randomized, Single Blind Study of Non-inferiority 89
The contribution of gut barrier changes to multiple sclerosis pathophysiology 89
Evidence for detrimental cross interactions between reactive oxygen and nitrogen species in Leber's hereditary optic neuropathy cells 88
Reworking GWAS data to understand the role of nongenetic factors in MS etiopathogenesis 88
Intestinal Permeability and Circulating CD161+CCR6+CD8+T Cells in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Dimethylfumarate 88
Early relapses after the first dose of natalizumab in active multiple sclerosis patients 87
Coincident onset of multiple sclerosis and herpes simplex virus 1 encephalitis. a case report 86
Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases 86
Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia 86
determinant spreading without disease progression in multiple sclerosis 85
Antinuclear antibodies and MRI activity in multiple sclerosis. 85
Vaccines in multiple sclerosis. The experience of BCG vaccination 85
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes. 85
Association between vaccines and neuroinflammation. time, risks, and benefits 85
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 85
Feasibility, Safety, and Effectiveness of Telerehabilitation in Mild-to-Moderate Parkinson's Disease 85
Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis. 84
Ofatumumab versus Teriflunomide in Multiple Sclerosis 84
Development of Neutralizing Antibodies in Patients with Relapsing-Remitting Multiple Sclerosis Treated with IFN-β1a 83
HSP70-1 promoter region polymorphism tested in three autoimmune diseases 83
Global immune disregulation in multiple sclerosis: from the adaptive response to the innate immunity 83
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 83
Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients 83
Chemical Elements and Oxidative Status in Neuroinflammation 83
Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study 83
Intestinal Permeabiliy in Relapsing-Remitting Multiple Sclerosis 82
Development of neutralizing antibodies in patients treated with IFN beta 1a 82
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 82
Multiple sclerosis etiology: beyond genes and environment 81
Noise in multiple sclerosis: unwanted and necessary 81
No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML 81
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. 81
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 81
Refining genetic associations in multiple sclerosis 80
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune diseases. 80
T LYMPHOCYTE RESPONSE TO POTENTIAL AUTOANTIGENS IN PATIENTS WITH MULTIPLE SCLEROSIS. 80
Multiple sclerosis progression is not associated with birth timing in Italy 80
Genome-Wide Multiple Sclerosis Association Data and Coagulation 80
A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis. 80
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins 79
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 79
Inverse correlation of genetic risk score with age at onset in bout-onset and progressiveonset multiple sclerosis 79
Association of Genetic Markers with CSF Oligoclonal Bands in Multiple Sclerosis Patients 79
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood 79
Mait cells and microbiota in multiple sclerosis and other autoimmune diseases 79
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins 79
Author correction. Transcriptional dysregulation of interferome in experimental and human multiple sclerosis 78
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 78
Early diagnosis of progressive multifocal leucoencephalopathy. longitudinal lesion evolution 78
A perspective of coagulation dysfunction in multiple sclerosis and in experimental allergic encephalomyelitis 78
Disentangling the molecular mechanisms of multiple sclerosis: the contribution of twin studies 78
Validation of the Canadian occupational performance measure in Italian Parkinson’s disease clients 78
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status 77
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets 77
Circulating hsa-miR-323b-3p in Huntington's Disease. A Pilot Study 77
A linkage analysis of multiple sclerosis with candidate region markers in Sardinian and continental Italian families 76
Effect of glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 76
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS. 76
Determinants of the severity of comorbid migraine in multiple sclerosis 76
Totale 9.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.922
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 455
selected - selezionate 0
volume - volumi 0
Totale 74.377
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.226 0 0 0 0 0 0 0 0 437 411 287 91
2020/20211.583 173 149 116 104 60 60 134 167 183 219 123 95
2021/20223.920 94 208 321 169 719 177 94 297 265 229 631 716
2022/20233.505 685 692 164 363 387 341 81 228 294 64 137 69
2023/20242.491 106 224 78 143 144 333 329 424 27 236 221 226
2024/20253.980 174 394 296 311 368 649 423 347 1.018 0 0 0
Totale 22.601